Page 1

Interim report January - September 2021 July - September 2021 in brief • Net sales increased to SEK 2,247 M ( 2,143 ) . Net sales grew organically by 5.1 % . Adjusted EBITDA increased 16.8 % to SEK 524 M ( 448 ) . Adjusted operating profit increased by 34.6 % to SEK 280 M ( 208 ) . • Profit after financial items increased to SEK 252 M ( 176 ) . Earnings per share rose to SEK 0.69 ( 0.49 ) . Cash flow from operations amounted to SEK 390 M ( 525 ) . ● ● Financial summary SEK M Net sales Gross profit Gross margin , % Quarter 3 2021 2,247 1,033 46.0 % 349 15.5 % 524 23.3 % 276 280 252 189 January - September 2021 in brief • Net sales amounted to SEK 6,614 M ( 6,680 ) . Net sales grew organically by 4.4 % . Adjusted EBITDA increased 10.7 % to SEK 1,531 M ( 1,383 ) . In comparable currencies , profit was SEK 1,586 M , corresponding to an improvement of about 15 % . Adjusted operating profit increased by 24.4 % to SEK 815 M ( 655 ) . In comparable currencies , profit was SEK 870 M , corresponding to an improvement of about 33 % . • Profit after financial items increased to SEK 736 M ( 468 ) . Earnings per share rose to SEK 2.03 ( 1.29 ) . • Cash flow from operations amounted to SEK 1,095 M ( 1,424 ) . ● Quarter 3 2020 2,143 973 45.4 % 277 12.9 % 448 20.9 % 208 208 176 132 Jan - Sep 2021 6,614 3,080 46.6 % 1,022 15.5 % 1,531 23.2 % Adjusted EBITA¹ ) Adjusted EBITA margin , % ¹ Adjusted EBITDA¹ ) Adjusted EBITDA margin , % ¹ ) Operating profit ( EBIT ) Adjusted operating profit ( EBIT ) ¹ ) Profit after financial items Net profit for the period Number of shares , thousands 272,370 Earnings per share , SEK 0.69 Cash flow from operations 390 75.0 % Cash conversion , % 1 ) Before exceptional items . See Alternative performance measures on page 18 and definitions on page 21 . 272,370 0.49 525 117.1 % 798 815 736 552 272,370 2.03 1,095 72.3 % Jan - Sep 2020 6,680 3,039 45.5 % 865 12.9 % 1,383 20.7 % 601 655 468 351 272,370 1.29 1,424 107.0 % The human body is made to move . At Arjo , we believe that high quality of care and positive clinical outcomes begin by maintaining or improving a patient's mobility . Our offering includes products and solutions for patient transfers , hygiene , disinfection , prevention of pres sure injuries and deep vein thrombosis ( blood clots ) and for diagnostics . We also offer medical beds and various services , such as training in connection with product sales . Arjo's approach contributes to improved quality of care and enhanced efficiency , resulting in reduced healthcare costs . www.arjo.com Rolling 12 months 9,012 4,167 46.2 % 1,382 15.3 % 2,061 22.9 % 1,063 1,103 969 727 272,370 2.67 1,938 95.9 % Full - year 2020 9,078 4,126 45.5 % 1,224 13.5 % 1,913 21.1 % 866 943 702 526 272,370 1.93 2,267 123.3 % arjo with people in mind